Health technology assessment: A primer for ophthalmology

被引:2
作者
Murphy, Aileen [1 ]
McElnea, Elizabeth [2 ]
Byrne, Sinead [3 ]
机构
[1] Univ Coll Cork, Cork Univ Business Sch, Dept Econ, Cork T12 T656, Ireland
[2] Mater Misericordiae Univ Hosp, Dublin, Ireland
[3] Mater Private Hosp Cork, Cork, Ireland
关键词
Health technology assessment; economic evaluation; cost effectiveness; ophthalmology; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; UNCERTAINTY; GLAUCOMA; MODEL;
D O I
10.1177/1120672117747040
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Rising healthcare costs and increasing demands for health care require techniques to choose between competing uses and even rationing of health care. Economic evaluations and health technology assessments are increasingly a means to assess the cost effectiveness of healthcare interventions so as to inform such resource allocation decisions. To date, the adoption of health technology assessments, as a way of assessing cost effectiveness, in ophthalmology has been slower, relative to their implementation in other specialities. Nevertheless, demands for eye services are increasing due to an ageing population. The prevalence of conditions such as glaucoma, cataract, diabetic eye disease and age-related macular degeneration increases with age, and it is predicted that global blindness will triple by 2050. So there is a challenge for ophthalmologists to ensure that they can contribute to, interpret, critically evaluate, and use findings from economic evaluations in their clinical practice. To aid this, this article serves as a primer on the use of health technology assessments to assess cost effectiveness using economic evaluation techniques for ophthalmologists. Healthcare systems face many challenges worldwide - changing demographics and evolution of new technologies are only going to intensify. With this in mind, ophthalmology needs to be ready and able to engage with health economists to prepare, interpret, critically evaluate and use findings of economic evaluations and health technology assessments.
引用
收藏
页码:358 / 364
页数:7
相关论文
共 29 条
  • [1] [Anonymous], 2008, TERMINOLOGY GUIDELIN, V3rd
  • [2] [Anonymous], 2015, METHODS EC EVALUATI
  • [3] [Anonymous], OPHTHAMOL MANAG
  • [4] Banta H.D., 1993, HLTH CARE TECHNOLOGY
  • [5] THE CE PLANE - A GRAPHIC REPRESENTATION OF COST-EFFECTIVENESS
    BLACK, WC
    [J]. MEDICAL DECISION MAKING, 1990, 10 (03) : 212 - 214
  • [6] Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
    Bourne, Rupert R. A.
    Flaxman, Seth R.
    Braithwaite, Tasanee
    Cicinelli, Maria V.
    Das, Aditi
    Jonas, Jost B.
    Keeffe, Jill
    Kempen, John H.
    Leasher, Janet
    Limburg, Hans
    Naidoo, Kovin
    Pesudovs, Konrad
    Resnikoff, Serge
    Silvester, Alex
    Stevens, Gretchen A.
    Tahhan, Nina
    Wong, Tien Y.
    Taylor, Hugh R.
    [J]. LANCET GLOBAL HEALTH, 2017, 5 (09): : E888 - E897
  • [7] An introduction to Markov modelling for economic evaluation
    Briggs, A
    Sculpher, M
    [J]. PHARMACOECONOMICS, 1998, 13 (04) : 397 - 409
  • [8] Briggs A., 2006, Decision modelling for health economic evaluation
  • [9] The death of cost-minimization analysis?
    Briggs, AH
    O'Brien, BJ
    [J]. HEALTH ECONOMICS, 2001, 10 (02) : 179 - 184
  • [10] Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
    Briggs, Andrew H.
    Weinstein, Milton C.
    Fenwick, Elisabeth A. L.
    Karnon, Jonathan
    Sculpher, Mark J.
    Paltiel, A. David
    [J]. VALUE IN HEALTH, 2012, 15 (06) : 835 - 842